Are There Specific Codes for Billing Covid-19 Surveillance Testing?

As the world continues to grapple with the effects of the Covid-19 pandemic, widespread testing has become a crucial tool in controlling the spread of the virus. Surveillance Testing, in particular, plays a key role in monitoring and tracking the prevalence of Covid-19 in communities. But when it comes to billing for these tests, Healthcare Providers may wonder if there are specific codes they need to use. In this article, we will explore the codes for billing Covid-19 Surveillance Testing and provide guidance on how to accurately submit claims for Reimbursement.

What is Covid-19 Surveillance Testing?

Covid-19 Surveillance Testing involves regularly testing individuals who do not have symptoms of Covid-19 to monitor the prevalence of the virus in a particular population or community. This type of testing is important for identifying asymptomatic carriers of the virus and preventing outbreaks in high-risk settings such as nursing homes, schools, and workplaces.

Why is Billing for Covid-19 Surveillance Testing Important?

Accurate and timely billing for Covid-19 Surveillance Testing is essential for Healthcare Providers to receive Reimbursement for the services they provide. By using the correct billing codes, providers can ensure that they are properly compensated for their efforts in conducting Surveillance Testing and contributing to public health efforts to control the spread of Covid-19.

Are There Specific Codes for Billing Covid-19 Surveillance Testing?

While there are not specific billing codes exclusively for Covid-19 Surveillance Testing, Healthcare Providers can use existing codes to submit claims for Reimbursement. The Centers for Medicare and Medicaid Services (CMS) and the American Medical Association (AMA) have established specific Current Procedural Terminology (CPT) codes for Covid-19 testing that can be used for Surveillance Testing as well.

CPT Codes for Covid-19 Testing

  1. CPT code 87635: Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [Covid-19]), amplified probe technique
  2. CPT code 86408: Covid-19 testing for influenza like illness (ILI)
  3. CPT code 87426: Infectious agent antigen detection by immunoassay technique, (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [Covid-19])

These CPT codes can be used when submitting claims for Covid-19 Surveillance Testing. It is important to accurately document the services provided and include the appropriate CPT code on the claim form to ensure proper Reimbursement.

Guidelines for Billing Covid-19 Surveillance Testing

When billing for Covid-19 Surveillance Testing, Healthcare Providers must follow certain guidelines to ensure compliance with federal Regulations and insurance requirements. Here are some key points to keep in mind:

Documentation Requirements

  1. Providers must document the medical necessity of the Covid-19 Surveillance Testing, including the reason for testing and the individual's risk factors.
  2. Documentation should include the date of the test, the type of test performed, and the results of the test.
  3. Providers should keep detailed records of all Covid-19 Surveillance Testing services provided, including any follow-up care or treatment.

Coding and Billing Procedures

  1. Use the appropriate CPT code for the type of Covid-19 test performed (e.g., nucleic acid test, antigen test).
  2. Include the diagnosis code for Covid-19 (ICD-10 code U07.1) on the claim form.
  3. Submit claims for Covid-19 Surveillance Testing services to the patient's insurance company or Medicare/Medicaid for Reimbursement.

Reimbursement Rates

  1. Reimbursement rates for Covid-19 Surveillance Testing may vary depending on the patient's Insurance Coverage and the type of test performed.
  2. Providers should verify the Reimbursement rates with the patient's insurance company or Medicare/Medicaid before submitting claims.
  3. Providers may also be eligible for Reimbursement from federal relief programs for Covid-19 testing and treatment services.

Conclusion

Accurate billing for Covid-19 Surveillance Testing is essential for Healthcare Providers to receive proper Reimbursement for their services. While there are not specific codes exclusively for Surveillance Testing, providers can use existing CPT codes for Covid-19 testing to submit claims for Reimbursement. By following the guidelines outlined in this article, providers can ensure that they are compliant with federal Regulations and insurance requirements when billing for Covid-19 Surveillance Testing.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on phlebotomy practices and healthcare. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Natalie Brooks, BS, CPT

Natalie Brooks is a certified phlebotomist with a Bachelor of Science in Medical Laboratory Science from the University of Florida. With 8 years of experience working in both clinical and research settings, Natalie has become highly skilled in blood collection techniques, particularly in high-volume environments. She is committed to ensuring that blood draws are conducted with the utmost care and precision, contributing to better patient outcomes.

Natalie frequently writes about the latest advancements in phlebotomy tools, strategies for improving blood collection efficiency, and tips for phlebotomists on dealing with difficult draws. Passionate about sharing her expertise, she also mentors new phlebotomists, helping them navigate the challenges of the field and promoting best practices for patient comfort and safety.

Previous
Previous

The Importance Of Training In Billing For Genetic And Molecular Tests In Phlebotomy

Next
Next

Are There Online Courses Available for Value-Based Care in Clinical Labs?